Hitoshi Ishiguro

4.5k total citations
107 papers, 3.8k citations indexed

About

Hitoshi Ishiguro is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Hitoshi Ishiguro has authored 107 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 24 papers in Materials Chemistry. Recurrent topics in Hitoshi Ishiguro's work include Prostate Cancer Treatment and Research (19 papers), Estrogen and related hormone effects (13 papers) and Advanced Nanomaterials in Catalysis (12 papers). Hitoshi Ishiguro is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Estrogen and related hormone effects (13 papers) and Advanced Nanomaterials in Catalysis (12 papers). Hitoshi Ishiguro collaborates with scholars based in Japan, United States and Australia. Hitoshi Ishiguro's co-authors include Yoshinobu Kubota, Hiroji Uemura, Hiroshi Miyamoto, Noboru Nakaigawa, Yoji Nagashima, Yasuhide Miyoshi, Hiroji Uemura, Takashi Kawahara, Kiyoshi Fujinami and Kayano Sunada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hitoshi Ishiguro

102 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Ishiguro Japan 38 1.3k 896 656 589 546 107 3.8k
Qing Miao China 45 2.9k 2.1× 344 0.4× 611 0.9× 682 1.2× 854 1.6× 203 6.5k
Elena Bonanno Italy 39 1.7k 1.3× 686 0.8× 1.0k 1.6× 714 1.2× 907 1.7× 156 5.2k
Tianyu Li China 41 1.4k 1.0× 640 0.7× 1.2k 1.9× 716 1.2× 534 1.0× 230 6.2k
Yulian Wu China 31 1.2k 0.9× 393 0.4× 722 1.1× 722 1.2× 375 0.7× 140 3.4k
Ya‐Wen Chen China 37 2.2k 1.6× 1.0k 1.2× 519 0.8× 864 1.5× 594 1.1× 139 5.4k
Kang Sun China 37 724 0.5× 592 0.7× 133 0.2× 330 0.6× 231 0.4× 174 3.9k
Lei Miao China 35 1.8k 1.4× 463 0.5× 868 1.3× 305 0.5× 674 1.2× 148 5.3k
Shinji Tamura Japan 38 1.5k 1.1× 181 0.2× 722 1.1× 623 1.1× 353 0.6× 255 5.9k
Jong Young Choi South Korea 36 1.2k 0.9× 457 0.5× 678 1.0× 759 1.3× 460 0.8× 239 5.2k
Jie Tang China 41 1.5k 1.2× 472 0.5× 815 1.2× 632 1.1× 491 0.9× 229 5.8k

Countries citing papers authored by Hitoshi Ishiguro

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Ishiguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Ishiguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Ishiguro more than expected).

Fields of papers citing papers by Hitoshi Ishiguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Ishiguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Ishiguro. The network helps show where Hitoshi Ishiguro may publish in the future.

Co-authorship network of co-authors of Hitoshi Ishiguro

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Ishiguro. A scholar is included among the top collaborators of Hitoshi Ishiguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Ishiguro. Hitoshi Ishiguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawa, Nanako O., et al.. (2025). Processing and antiviral activity of Cu-modified (Ce<sub>0.8</sub>,Gd<sub>0.2</sub>)O<sub>2−δ</sub> in the dark and under visible light. Journal of the Ceramic Society of Japan. 133(8). 474–480.
2.
Sunada, Kayano, et al.. (2024). Effects of UV illumination on organic dye decomposition activity and antibacterial and antiviral activities of rare earth iodates. Journal of Materials Science. 59(37). 17558–17572.
3.
4.
Sunada, Kayano, Toshihiro Isobe, Sachiko Matsushita, et al.. (2023). Preparation of rare earth iodates and their decomposition activity on organic dyes and antibacterial/antiviral activities. Ceramics International. 49(9). 14681–14688. 7 indexed citations
5.
Sunada, Kayano, et al.. (2023). Degradation of 2-naphthol in water and antibacterial/antiviral activity by Zn2SnO4, ZnSn(OH)6 and Y2Sn2O7. Ceramics International. 50(7). 10797–10805. 4 indexed citations
6.
7.
Ishiguro, Hitoshi, et al.. (2022). Antibacterial effect on microscale rough surface formed by fine particle bombarding. AMB Express. 12(1). 9–9. 9 indexed citations
8.
Nakano, Ryuichi, Akira Yamaguchi, Kayano Sunada, et al.. (2022). Inactivation of various variant types of SARS-CoV-2 by indoor-light-sensitive TiO2-based photocatalyst. Scientific Reports. 12(1). 5804–5804. 36 indexed citations
9.
Minoshima, Masafumi, Yue Lü, Ryuichi Nakano, et al.. (2016). Comparison of the antiviral effect of solid-state copper and silver compounds. Journal of Hazardous Materials. 312. 1–7. 116 indexed citations
10.
Kato, Shingo, Kazunori Akimoto, Yoji Nagashima, et al.. (2013). aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology. 13(4). 360–368. 17 indexed citations
11.
Zheng, Yichun, Koji Izumi, Yi Li, Hitoshi Ishiguro, & Hiroshi Miyamoto. (2012). Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals. Molecular Cancer Therapeutics. 11(12). 2621–2632. 62 indexed citations
12.
Kato, Shingo, Kensuke Kubota, Takeshi Shimamura, et al.. (2011). Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Science. 102(11). 2029–2037. 51 indexed citations
13.
Ohta, Shinsuke, Hiroji Uemura, Yoshiro Matsui, et al.. (2008). Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 107(1). 81–91. 53 indexed citations
14.
Uemura, Hiroji, Hitoshi Ishiguro, & Yoshinobu Kubota. (2007). Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment. International Journal of Urology. 15(1). 19–26. 29 indexed citations
15.
Miyamoto, Hiroshi, Zhi Yang, Yei‐Tsung Chen, et al.. (2007). Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals. JNCI Journal of the National Cancer Institute. 99(7). 558–568. 330 indexed citations
16.
Uemura, Hiroji, Hisashi Hasumi, Hitoshi Ishiguro, et al.. (2006). Renin‐angiotensin system is an important factor in hormone refractory prostate cancer. The Prostate. 66(8). 822–830. 54 indexed citations
17.
Uemura, Hiroji, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, & Yoshinobu Kubota. (2005). Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and prostate cancer cells. Cancer Research. 65. 555–555. 1 indexed citations
18.
Hasumi, Hisashi, Hitoshi Ishiguro, Masashi Nakamura, et al.. (2005). Neuroserpin (PI‐12) is upregulated in high‐grade prostate cancer and is associated with survival. International Journal of Cancer. 115(6). 911–916. 20 indexed citations
19.
Uemura, Hiroji, Noboru Nakaigawa, Hitoshi Ishiguro, & Yoshinobu Kubota. (2005). Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer. Current Cancer Drug Targets. 5(5). 307–323. 43 indexed citations
20.
Uemura, Hiroji, et al.. (2005). Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer. Prostate Cancer and Prostatic Diseases. 8(3). 260–265. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Miao Breakdown of academic impact, for papers by Elena Bonanno Breakdown of academic impact, for papers by Tianyu Li Breakdown of academic impact, for papers by Yulian Wu Breakdown of academic impact, for papers by Ya‐Wen Chen Breakdown of academic impact, for papers by Kang Sun Breakdown of academic impact, for papers by Lei Miao Breakdown of academic impact, for papers by Shinji Tamura Breakdown of academic impact, for papers by Jong Young Choi Breakdown of academic impact, for papers by Jie Tang
Rankless by CCL
2026